EconPapers    
Economics at your fingertips  
 

How a pioneering diabetes drug offers hope for preventing autoimmune disorders

Elie Dolgin

Nature, 2023, vol. 614, issue 7948, 404-406

Abstract: The approval of an antibody therapy that pauses the progression of type 1 diabetes is a first in the field, and some say a model for other drug developers.

Keywords: Diabetes; Drug discovery; Immunology (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-023-00400-x Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:614:y:2023:i:7948:d:10.1038_d41586-023-00400-x

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-00400-x

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:614:y:2023:i:7948:d:10.1038_d41586-023-00400-x